BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 27623776)

  • 1. Nebivolol suppresses cardiac ryanodine receptor-mediated spontaneous Ca2+ release and catecholaminergic polymorphic ventricular tachycardia.
    Tan Z; Xiao Z; Wei J; Zhang J; Zhou Q; Smith CD; Nani A; Wu G; Song LS; Back TG; Fill M; Chen SR
    Biochem J; 2016 Nov; 473(22):4159-4172. PubMed ID: 27623776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced threshold for store overload-induced Ca
    Chen W; Koop A; Liu Y; Guo W; Wei J; Wang R; MacLennan DH; Dirksen RT; Chen SRW
    Biochem J; 2017 Aug; 474(16):2749-2761. PubMed ID: 28687594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-β-blocking R-carvedilol enantiomer suppresses Ca2+ waves and stress-induced ventricular tachyarrhythmia without lowering heart rate or blood pressure.
    Zhang J; Zhou Q; Smith CD; Chen H; Tan Z; Chen B; Nani A; Wu G; Song LS; Fill M; Back TG; Chen SR
    Biochem J; 2015 Sep; 470(2):233-42. PubMed ID: 26348911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carvedilol and its new analogs suppress arrhythmogenic store overload-induced Ca2+ release.
    Zhou Q; Xiao J; Jiang D; Wang R; Vembaiyan K; Wang A; Smith CD; Xie C; Chen W; Zhang J; Tian X; Jones PP; Zhong X; Guo A; Chen H; Zhang L; Zhu W; Yang D; Li X; Chen J; Gillis AM; Duff HJ; Cheng H; Feldman AM; Song LS; Fill M; Back TG; Chen SR
    Nat Med; 2011 Jul; 17(8):1003-9. PubMed ID: 21743453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CPVT-associated RyR2 mutation G230C enhances store overload-induced Ca2+ release and destabilizes the N-terminal domains.
    Liu Y; Kimlicka L; Hiess F; Tian X; Wang R; Zhang L; Jones PP; Van Petegem F; Chen SR
    Biochem J; 2013 Aug; 454(1):123-31. PubMed ID: 23746327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phospholamban knockout breaks arrhythmogenic Ca²⁺ waves and suppresses catecholaminergic polymorphic ventricular tachycardia in mice.
    Bai Y; Jones PP; Guo J; Zhong X; Clark RB; Zhou Q; Wang R; Vallmitjana A; Benitez R; Hove-Madsen L; Semeniuk L; Guo A; Song LS; Duff HJ; Chen SR
    Circ Res; 2013 Aug; 113(5):517-26. PubMed ID: 23856523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RYR2 Channel Inhibition Is the Principal Mechanism of Flecainide Action in CPVT.
    Kryshtal DO; Blackwell DJ; Egly CL; Smith AN; Batiste SM; Johnston JN; Laver DR; Knollmann BC
    Circ Res; 2021 Feb; 128(3):321-331. PubMed ID: 33297863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of store overload-induced calcium release by hydroxylated metabolites of carvedilol.
    Malig T; Xiao Z; Chen SR; Back TG
    Bioorg Med Chem Lett; 2016 Jan; 26(1):149-53. PubMed ID: 26584883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RyR2 mutations linked to ventricular tachycardia and sudden death reduce the threshold for store-overload-induced Ca2+ release (SOICR).
    Jiang D; Xiao B; Yang D; Wang R; Choi P; Zhang L; Cheng H; Chen SR
    Proc Natl Acad Sci U S A; 2004 Aug; 101(35):13062-7. PubMed ID: 15322274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced Cytosolic Ca2+ Activation Underlies a Common Defect of Central Domain Cardiac Ryanodine Receptor Mutations Linked to Arrhythmias.
    Xiao Z; Guo W; Sun B; Hunt DJ; Wei J; Liu Y; Wang Y; Wang R; Jones PP; Back TG; Chen SRW
    J Biol Chem; 2016 Nov; 291(47):24528-24537. PubMed ID: 27733687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of ryanodine receptor function prolongs Ca2+ release refractoriness and promotes cardiac alternans in intact hearts.
    Zhong X; Sun B; Vallmitjana A; Mi T; Guo W; Ni M; Wang R; Guo A; Duff HJ; Gillis AM; Song LS; Hove-Madsen L; Benitez R; Chen SR
    Biochem J; 2016 Nov; 473(21):3951-3964. PubMed ID: 27582498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CPVT-associated cardiac ryanodine receptor mutation G357S with reduced penetrance impairs Ca2+ release termination and diminishes protein expression.
    Liu Y; Wei J; Wong King Yuen SM; Sun B; Tang Y; Wang R; Van Petegem F; Chen SRW
    PLoS One; 2017; 12(9):e0184177. PubMed ID: 28961276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Na+-dependent SR Ca2+ overload induces arrhythmogenic events in mouse cardiomyocytes with a human CPVT mutation.
    Sedej S; Heinzel FR; Walther S; Dybkova N; Wakula P; Groborz J; Gronau P; Maier LS; Vos MA; Lai FA; Napolitano C; Priori SG; Kockskämper J; Pieske B
    Cardiovasc Res; 2010 Jul; 87(1):50-9. PubMed ID: 20080988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paradoxical effect of increased diastolic Ca(2+) release and decreased sinoatrial node activity in a mouse model of catecholaminergic polymorphic ventricular tachycardia.
    Neco P; Torrente AG; Mesirca P; Zorio E; Liu N; Priori SG; Napolitano C; Richard S; Benitah JP; Mangoni ME; Gómez AM
    Circulation; 2012 Jul; 126(4):392-401. PubMed ID: 22711277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In situ confocal imaging in intact heart reveals stress-induced Ca(2+) release variability in a murine catecholaminergic polymorphic ventricular tachycardia model of type 2 ryanodine receptor(R4496C+/-) mutation.
    Chen B; Guo A; Gao Z; Wei S; Xie YP; Chen SR; Anderson ME; Song LS
    Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):841-9. PubMed ID: 22722659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel carvedilol analogues that suppress store-overload-induced Ca2+ release.
    Smith CD; Wang A; Vembaiyan K; Zhang J; Xie C; Zhou Q; Wu G; Chen SR; Back TG
    J Med Chem; 2013 Nov; 56(21):8626-55. PubMed ID: 24124794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A gain of function ryanodine receptor 2 mutation (R1760W-RyR2) in catecholaminergic polymorphic ventricular tachycardia.
    Li S; Lv T; Yang J; Li K; Yang Y; Zhang P
    Clin Exp Pharmacol Physiol; 2023 Jan; 50(1):39-49. PubMed ID: 36082968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Removal of FKBP12.6 does not alter the conductance and activation of the cardiac ryanodine receptor or the susceptibility to stress-induced ventricular arrhythmias.
    Xiao J; Tian X; Jones PP; Bolstad J; Kong H; Wang R; Zhang L; Duff HJ; Gillis AM; Fleischer S; Kotlikoff M; Copello JA; Chen SR
    J Biol Chem; 2007 Nov; 282(48):34828-38. PubMed ID: 17921453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cardiac Ca2+ release channels (RyR2) determines efficacy of class I antiarrhythmic drugs in catecholaminergic polymorphic ventricular tachycardia.
    Hwang HS; Hasdemir C; Laver D; Mehra D; Turhan K; Faggioni M; Yin H; Knollmann BC
    Circ Arrhythm Electrophysiol; 2011 Apr; 4(2):128-35. PubMed ID: 21270101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ryanodine receptor 2 inhibition reduces dispersion of cardiac repolarization, improves contractile function, and prevents sudden arrhythmic death in failing hearts.
    Joshi P; Estes S; DeMazumder D; Knollmann BC; Dey S
    Elife; 2023 Dec; 12():. PubMed ID: 38078905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.